Richard Meenan to Cost-Benefit Analysis
This is a "connection" page, showing publications Richard Meenan has written about Cost-Benefit Analysis.
Connection Strength
0.980
-
Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening. JAMA Netw Open. 2023 03 01; 6(3):e234052.
Score: 0.200
-
Economic Evaluation of a Sun Protection Promotion Program in California Elementary Schools. Am J Health Promot. 2020 11; 34(8):848-856.
Score: 0.162
-
An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic Medications. Adm Policy Ment Health. 2016 07; 43(4):604-15.
Score: 0.126
-
An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015 Jun; 48(6):714-21.
Score: 0.117
-
Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack. Med Decis Making. 2007 Mar-Apr; 27(2):161-77.
Score: 0.066
-
Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis. Qual Life Res. 2005 May; 14(4):1127-33.
Score: 0.058
-
Creating standard cost measures across integrated health care delivery systems. J Natl Cancer Inst Monogr. 2005; (35):80-7.
Score: 0.057
-
Effectiveness and cost-effectiveness of echocardiography and carotid imaging in the management of stroke. Evid Rep Technol Assess (Summ). 2002 Jul; (49):1-10.
Score: 0.048
-
Developing appropriate measures of the benefits of complementary and alternative medicine. J Health Serv Res Policy. 2001 Jan; 6(1):38-43.
Score: 0.043
-
Cost-effectiveness of a hospital-based smoking cessation intervention. Med Care. 1998 May; 36(5):670-8.
Score: 0.036
-
Strategies and Opportunities to STOP Colon Cancer in Priority Populations: design of a cluster-randomized pragmatic trial. Contemp Clin Trials. 2014 Jul; 38(2):344-9.
Score: 0.027
-
Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. J Natl Cancer Inst. 2012 Dec 05; 104(23):1785-95.
Score: 0.025
-
Opportunities and challenges for measuring cost, quality, and clinical effectiveness in health care. Med Care Res Rev. 2004 Sep; 61(3 Suppl):124S-43S.
Score: 0.014